Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Labeling DNA Probes03:31

Labeling DNA Probes

9.9K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.9K
In-situ Hybridization02:31

In-situ Hybridization

11.5K
In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
11.5K
Ligand Binding Sites02:40

Ligand Binding Sites

15.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitor.

npj drug discovery·2026
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026
Same author

CpG island density predicts CBP/p300 dependency across 3D chromatin clusters.

bioRxiv : the preprint server for biology·2026
Same author

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium.

Pediatric blood & cancer·2026
Same author

Heritable immunization of mice against Lyme disease enables ecological disease prevention.

Nature communications·2026
Same author

Development of PROTACs for targeted degradation of oncogenic TRK fusions.

RSC chemical biology·2026

Related Experiment Video

Updated: Apr 20, 2026

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics
11:40

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Published on: June 23, 2022

3.1K

Structure-guided DOT1L probe optimization by label-free ligand displacement.

Joanna S Yi1,2,3, Alexander J Federation1, Jun Qi1

  • 1†Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States.

ACS Chemical Biology
|November 15, 2014
PubMed
Summary

Researchers developed new, miniaturized assays to discover and optimize DOT1L inhibitors for MLL-rearranged leukemias. These assays improve cellular potency and selectivity, offering a platform for developing better small-molecule drugs.

More Related Videos

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.5K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

810

Related Experiment Videos

Last Updated: Apr 20, 2026

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics
11:40

Characterization of Neuronal Lysosome Interactome with Proximity Labeling Proteomics

Published on: June 23, 2022

3.1K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

13.5K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

810

Area of Science:

  • Biochemistry
  • Oncology
  • Drug Discovery

Background:

  • DOT1L lysine methyltransferase is a therapeutic target in MLL-rearranged (MLLr) acute leukemias.
  • Existing DOT1L inhibitors require optimization for cellular potency and pharmacokinetic stability.
  • Current discovery and optimization methods are complex and time-consuming.

Purpose of the Study:

  • To develop novel, miniaturized assay technologies for DOT1L inhibitor assessment.
  • To gain new insights into DOT1L ligand binding through integrated structural information.
  • To identify potent and selective small-molecule DOT1L inhibitors.

Main Methods:

  • Development of a new suite of miniaturized assay technologies for comparative assessment of DOT1L chemical tools.
  • Integration of assay data with structural information to understand DOT1L ligand binding.
  • Screening and optimization of functionalized probes.

Main Results:

  • Identification of functionalized probes with increased cellular potency (IC50 values ~10 nM).
  • Demonstration of excellent selectivity for DOT1L among identified probes.
  • Establishment of a platform capability for DOT1L inhibitor discovery and optimization.

Conclusions:

  • The new assay technologies enable efficient discovery and optimization of small-molecule DOT1L inhibitors.
  • These advancements facilitate the development of improved therapeutics for MLLr acute leukemias.
  • The developed platform supports future research in DOT1L-targeted therapies.